Hjem
Peter Schusters bilde

Peter Schuster

Førsteamanuensis
  • E-postPeter.Schuster@uib.no
  • Telefon+47 55 97 22 20
  • Besøksadresse
    Haukeland universitetssykehus, Laboratoriebygget
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • 2019. Troponin T release comparing manually or magnetically guided radiofrequency ablation for AVNRT- a MAGMA AVNRT substudy. Scandinavian Cardiovascular Journal. 362-366.
  • 2019. Accuracy and usability of single-lead ECG from smartphones - A clinical study. Indian Pacing and Electrophysiology Journal.
  • 2018. Long-term follow-up in patients treated by stent implantation for post-ablation pulmonary vein stenosis. Journal of interventional cardiac electrophysiology. 309-315.
  • 2018. Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation. International Journal of Cardiology. 7 sider.
  • 2018. Entrapment and retrieval of a diagnostic electrophysiological catheter in the Chiari network. Journal of Arrhythmia. 647-649.
  • 2018. 18 års oppfølging etter radiofrekvens kateterablasjon for atrioventrikulær nodal reentrytakykardi. Hjerteforum. 25-28.
  • 2017. Multicenter, randomized comparison between magnetically navigated and manually guided radiofrequency ablation of atrioventricular nodal reentrant tachycardia (the MagMa-AVNRT-trial). Clinical Research in Cardiology. 947-952.
  • 2017. Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter. Scandinavian Cardiovascular Journal. 123-128.
  • 2017. Atrioventricular nodal ablation in patients with resynchronization therapy and atrial fibrillation?long term results. Scandinavian Cardiovascular Journal. 138-142.
  • 2016. 10-year follow-up after radiofrequency ablation of idiopathic ventricular arrhythmias from right ventricular outflow tract. Indian Pacing and Electrophysiology Journal. 88-91.
  • 2015. Premedication and preoperative information reduces pain intensity and increases satisfaction in patients undergoing ablation for atrial fibrillation. A randomised controlled study. Applied Nursing Research. 268-273.
  • 2013. Long-term outcomes of adjunctive complex fractionated electrogram ablation to pulmonary vein isolation as treatment for non-paroxysmal atrial fibrillation. Journal of interventional cardiac electrophysiology. 19-26.
  • 2013. Ablation effect indicated by impedance fall is correlated with contact force level during ablation for atrial fibrillation. Cardiovascular Electrophysiology. 1210-1215.
  • 2012. Ventricular arrhythmias originating from the aortomitral continuity: an uncommon variant of left ventricular outflow tract tachycardia. Europace. 388-395.
  • 2012. N-terminal pro-B-type natriuretic peptide level at long-term follow-up after atrial fibrillation ablation: a marker of reverse atrial remodelling and successful ablation. Journal of interventional cardiac electrophysiology. 129-136.
  • 2011. Remote magnetic versus manual catheters: evaluation of ablation effect in atrial fibrillation by myocardial marker levels. Journal of interventional cardiac electrophysiology. 37-43.
  • 2010. TEE time? ICETEE time! IntraCardiac Echocardiography probe used for TransoEsophageal Echocardiography. Europace. 1787-1788.
  • 2010. Characteristics and distribution of complex fractionated atrial electrograms in patients with paroxysmal and persistent atrial fibrillation. Journal of interventional cardiac electrophysiology. 87-93.
  • 2009. Spatial relationships between the pulmonary veins and sites of complex fractionated atrial electrograms during atrial fibrillation. Pacing and Clinical Electrophysiology. S190-S193.
  • 2009. Atrio-pulmonary vein conduction delay during pulmonary vein isolation for atrial fibrillation is related to vein anatomy, age, and focal activity. Pacing and Clinical Electrophysiology. S207-S210.
  • 2009. Ablasjonsbehandling av takyarytmier hos barn og unge. Tidsskrift for Den norske legeforening. 291-295.
  • 2008. Treatment of atrial fibrillation by silencing electrical activity in the posterior inter-pulmonary-vein atrium. Europace. 265-272.
  • 2005. Reducing atrial tachycardia and atrial fibrillation episodes with a prevention and treatment device and tailored treatment. International Journal of Cardiology. 51-58.
  • 2005. Proportionality of rate response to metabolic workload provided by a rate adaptive pacemaker with automatic rate profile optimization. Europace. 54-59.
  • 2005. Device treatment of atrial tachycardia - minor additional effect of repeating pacing sequences. International Journal of Cardiology. 10-14.
  • 2005. Assessment of regional timing of left ventricular sytolic longitudinal movement by Doppler tissue synchronization imaging in structurally normal hearts. European Heart Journal-Cardiovascular Imaging. 336-343.
Brev til redaktøren
  • 2018. Letter by Schuster Regarding Article, "Outcomes and Management of Patients With Severe Pulmonary Vein Stenosis From Prior Atrial Fibrillation Ablation". Circulation: Arrhythmia and Electrophysiology.
Intervju
  • 2018. Dette er symptomene du må være OBS på.
Sammendrag/abstract
  • 2009. There is a relation between self-reported arrhythmia burden, atrial size and pro-brain natriuretic peptide in atrial fibrillation patients. Cardiology. 71-71.
  • 2009. Biochemical marker levels after ablation for atrial fibrillation: difference between remote magnetic and conventional irrigated catheter. Cardiology. 70-70.
Vitenskapelig oversiktsartikkel/review
  • 2016. AV-knuteablasjon- en undervurdert behandling? 26-30.
  • 2015. Radiofrekvenskateterablasjon hos pasienter med ikke-paroksysmal atrieflimmer? 45-46.
  • 2012. Catheter ablation of typical atrial flutter. 29-32.
  • 2010. Magnetstyrt ablasjonsbehandling av hjerterytmeforstyrrelser :. 1467-1470.

Se fullstendig oversikt over publikasjoner i CRIStin.